Actively Recruiting
TriMaximize: A Multicentre, Prospective, Non-interventional Trial in Asthma Patients
Led by Chiesi Poland Sp. z o.o. · Updated on 2024-08-23
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
C
Chiesi Poland Sp. z o.o.
Lead Sponsor
G
Gesellschaft für Therapieforschung mbH
Collaborating Sponsor
AI-Summary
What this Trial Is About
TriMaximize: A multicentre, prospective, non-interventional trial monitoring therapy pathways of asthma patients treated with an extra-fine ICS/LABA/LAMA single-inhaler triple therapy in a real-world setting and characterizing the effects on health-related outcomes.
CONDITIONS
Official Title
TriMaximize: A Multicentre, Prospective, Non-interventional Trial in Asthma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years of age or older
- Confirmed diagnosis of asthma with or without COPD
- Doctor's decision to start fixed triple therapy with Trimbow (medium or high strength) based on current approved use
- Willing and able to provide informed consent for use of pseudonymised clinical data
You will not qualify if you...
- Participation in an interventional clinical trial within 30 days before enrollment
- Planned participation in an interventional clinical trial during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Indywidualna Specjalistyczna Praktyka Lekarska
Tarnowskie Góry, Poland, 42-609
Actively Recruiting
Research Team
T
Tomasz Debowski, Md Phd
CONTACT
M
Maciej Wojakiewicz, Phd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here